ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,071.17
      0.53%
      US Tech 100
      20,980.00
      0.70%
      Dow Jones
      44,882.13
      0.38%
      Brent Oil
      76.05
      0.17%
      Bitcoin
      105,100.00
      1.31%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. NovoCure Ltd (NVCR)

      7. NovoCure Ltd (NVCR) News

      NovoCure Ltd

      NovoCure Ltd (NVCR)

      NASDAQ
      25.51
      -0.01
      (-0.04%)
      At close: January 30 4:00PM
      Delayed by 15 minutes
      25.51
      0.00
      ( 0.00% )
      After Hours: 5:36PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      NVCR News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 15 2025
      NVCR (-0.04%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      January 13 2025
      NVCR (-0.04%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 13 2025
      NVCR (-0.04%)

      Form 3 - Initial statement of beneficial ownership of securities
      Edgar (US Regulatory)
      January 06 2025
      NVCR (-0.04%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 02 2024
      NVCR (-0.04%)

      NVCR Discussion

      View Posts
      jondoeuk jondoeuk 3 weeks ago
      KEYNOTE-D58 is a pivotal trial (N=741) of Optune concomitant with temozolomide plus keytruda in ndGBM. The estimated primary completion date is April 2029.
      👍️0
      jondoeuk jondoeuk 3 weeks ago
      Data from the PhII 2-THE-TOP trial https://www.onclive.com/view/temozolomide-pembrolizumab-plus-ttfields-leads-to-tumor-control-in-newly-diagnosed-glioblastoma
      👍️0
      KIPK KIPK 3 weeks ago
      dennisbabe - You are not smart enough to be impactful one way or another..
      You are just one irrelevant poster.....
      👍️0
      KIPK KIPK 3 weeks ago
      LOL - Garbage post....
      👍️0
      PonkenPlonken PonkenPlonken 3 weeks ago
      thank you very much for sharing jondoeuk!
      👍️0
      jondoeuk jondoeuk 3 weeks ago
      It is a pilot trial, but mPDAC is the largest category at diagnosis. Depending on the data (and if a pivotal trial ends up being successful), TTFs could eventually be used across all diagnosis categories.
      👍️0
      whosleftholdindabag whosleftholdindabag 1 month ago
      Wishing a Happy New Year to everyone who is invested in $NVCR!
      👍️0
      KIPK KIPK 1 month ago
      dennisdave, you & FeMike are made for each other. The two Irrelevant Scam Artistwannabies, begging for attention..

      You are both piles of SSSSSSSSSSSSS.......HIT....
      👍️0
      KIPK KIPK 1 month ago
      And you jondickuk, crawling around to save your clients from bad advise you capable of giving..

      LOL....
      👍️0
      whosleftholdindabag whosleftholdindabag 2 months ago
      $NVCR has reached its 52-week high! Wishing everyone a great weekend! GLTA
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      Thank you for sharing!
      They seem to believe this makes it to market in CRC is my read.
      👍️0
      jondoeuk jondoeuk 2 months ago
      A phase 2 trial, PANOVA-4, will test TTFields combined with a triplet regimen of gemcitabine, nab-paclitaxel and atezolizumab as a first-line treatment for metastatic pancreatic ductal adenocarcinoma. It has completed enrolment and the company said it expects to have data in 2026.

      The primary endpoint is disease control rate (DCR). Secondary endpoints include, overall survival (OS), progression-free survival (PFS), 1-year OS rate, objective response rate (ORR), PFS at 6 months, duration of response, and safety.
      👍️0
      whosleftholdindabag whosleftholdindabag 2 months ago
      $NVCR what a great way to kick off December, don't you know? Where are all the bloody naysayers today? We're raising a lot of money for charity! GLTA
      👍️0
      jondoeuk jondoeuk 2 months ago
      Novocure plans to file for regulatory approval in the U.S., EU, Japan and other key markets; Zai Lab plans to file for regulatory approval in China https://www.businesswire.com/news/home/20241202363277/en/Zai-Lab-and-Novocure-Announce-Positive-Topline-Results-from-Phase-3-PANOVA-3-Clinical-Trial-of-Tumor-Treating-Fields-TTFields-Therapy-for-Pancreatic-Cancer
      👍️ 1
      tw0122 tw0122 2 months ago
      Looking good $30 +
      50% 
      12:09 PM EST, 12/02/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.)NovoCure's (NVCR) shares rose more than 41% in recent Monday trading after the company and Zai Lab (ZLAB) said that their phase 3 trial evaluating TTFields along with gemcitabine and nab-paclitaxel as a treatment for unresectable, locally advanced pancreatic adenocarcinoma achieved its primary endpoint, demonstrating a "statistically significant" improvement in median overall survival.NovoCure (NVCR) plans regulatory filings in the US, EU, Japan, and other major markets, while Zai Lab plans to file for regulatory approval in China, the companies said.
      👍️0
      PonkenPlonken PonkenPlonken 2 months ago
      would love to see new session high
      data is hot --- Can become SOC
      👍️0
      whosleftholdindabag whosleftholdindabag 2 months ago
      $NVCR back above $20! GLTA
      👍️0
      Invest-in-America Invest-in-America 3 months ago
      NVCR: One has to be patently BRAIN DEAD to attribute any significance whatsoever to the 1890's-like ELECTRICAL, cure-all, gadgets that this obvious SCAM company promotes!!!
      👍️ 1
      jondoeuk jondoeuk 4 months ago
      FDA Approves Novocure’s Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer https://www.businesswire.com/news/home/20241015381082/en
      👍️ 1 💥 1
      whosleftholdindabag whosleftholdindabag 4 months ago
      Lovely action AH $NVCR! I can't wait for the opening bell, wishing everyone a great evening! GLTA
      👍️0
      whosleftholdindabag whosleftholdindabag 4 months ago
      $NVCR great way to end the trading day! GLTA
      👍️0
      whosleftholdindabag whosleftholdindabag 4 months ago
      I own both $NVCR and $NWBO, all proceeds will go to charity. GLTA
      👍️0
      KIPK KIPK 4 months ago
      Glad to see you are in the right stock, NWBO, now!!
      👍️0
      TiltMyBrain TiltMyBrain 5 months ago
      Who is the bag holder now???

      Going to single digits
      👍️ 1
      whosleftholdindabag whosleftholdindabag 6 months ago
      Come fly with me, let's fly let's fly away! Ol blue eyes, what a beautiful voice! Great start $NVCR! GLTA
      🚽 1
      whosleftholdindabag whosleftholdindabag 6 months ago
      Back above $20 $NVCR! GLTA
      👍️0
      whosleftholdindabag whosleftholdindabag 8 months ago
      Another week, another beautiful day for $NVCR shareholders! GLTA
      🐀 1
      whosleftholdindabag whosleftholdindabag 8 months ago
      Another beautiful start of the week for $NVCR! GLTA
      👍️0
      KIPK KIPK 8 months ago
      LOL - Go from over $200 to $20.
      Wondering why this charity worker is NWBO hater.
      Wondering why a self proclaimed good spirit tries so hard to destroy a great cancer therapy company. NWBO, hat is not NVCR??
      A true charity worker expected to be compassionate, caring, and greatful of all possible potentials...

      BUT not this guy??

      You judge!!!

      KARMA!!
      👍️ 3 💯 2
      whosleftholdindabag whosleftholdindabag 9 months ago
      GO $NVCR GO! We're making A LOT of $$$$$ for charities don't you know? GLTA
      ⚠️ 1
      whosleftholdindabag whosleftholdindabag 9 months ago
      Beautiful day $NVCR! GLTA
      👎️ 1 🤣 2
      whosleftholdindabag whosleftholdindabag 9 months ago
      It's been another great week for $NVCR! Have a wonderful weekend everyone! GLTA
      👎️ 1 🚫 1 🤣 1
      TiltMyBrain TiltMyBrain 9 months ago
      Insiders to sell shares in 30 days
      👍️ 2 💥 2
      KIPK KIPK 9 months ago
      LOL 🤣🤣🤣
      👍️ 1 💯 1
      dstock07734 dstock07734 9 months ago
      Or you can simply wait.
      👍️ 1 🤣 2
      whosleftholdindabag whosleftholdindabag 9 months ago
      Well that's fantastic mate! Perhaps I'll have my lawyer contact her, have a great weekend! GLTA
      🤣 1 ⚠️ 1
      dstock07734 dstock07734 9 months ago
      By now, you should be smart enough to know that Laura Posner or Elliott Leary would be able to get IP address of each poster on NWBO board.
      👍️ 3
      dstock07734 dstock07734 9 months ago
      libel? Which part is libel? Nemesis18's post style is very similar to yours, would you agree?
      👍️ 3 🤣 2
      whosleftholdindabag whosleftholdindabag 9 months ago
      No, do you? GLTA
      ⚠️ 1
      whosleftholdindabag whosleftholdindabag 9 months ago
      I'd be careful you're getting a wee bit close to libel don't you know? GLTA
      🚫 1 🤣 1
      whosleftholdindabag whosleftholdindabag 9 months ago
      Great way to end the week! Finish strong $NVCR! Have a great weekend everyone! GLTA
      🚫 1 🤣 1
      whosleftholdindabag whosleftholdindabag 9 months ago
      You're posting on the wrong board mate, $NWBO is the one dealing with toxic financers go over there and post your rubbish! GLTA

      Streeterville Capital, LLC is a Chicago-based company owned by John M. Fife, who has been described as a "toxic lender" for many years. Toxic financing is a type of financing that companies use when they are in poor condition and can't get financing in any other way. It can come in the form of convertible debt or convertible preferred stock and often gives the debtholder an unlimited number of common shares when they convert their debt or preferred shares to common stock.
      👍️ 1
      TiltMyBrain TiltMyBrain 9 months ago
      Toxic financing for a company who’s price is down 90% in last 3 years
      👍️ 2 💥 2
      TiltMyBrain TiltMyBrain 9 months ago
      Today is the pump. Tomorrow is the insider dump
      👍️ 2 💥 2
      KIPK KIPK 9 months ago
      What a great day right Nemeses 18?
      How is dat charity holding da bag???
      👍️ 1 😂 2 🤣 1
      KIPK KIPK 9 months ago
      Gone with the wind on wings of fake therapy IMO
      👍️ 1 💯 1
      KIPK KIPK 10 months ago
      20? including a PRE-CLINICAL???? lol
      And all that unfocused activity signal the total desperation to keep the SP up IMO...

      Reminds me of INO, which also kept throwing stuff at every possible thing, hoping one would stick.... But NO... INO SP at one time was over $2000 & now is around $11 after a recent RS
      👍️0
      axelvento axelvento 10 months ago
      Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

      https://www.biospace.com/article/releases/novocure-announces-20-presentations-on-tumor-treating-fields-highlighting-preclinical-effects-in-pancreatic-cancer-and-immune-effects-at-american-association-for-cancer-research-aacr-annual-meeting-2024/
      👎️ 2 🤣 1
      TiltMyBrain TiltMyBrain 10 months ago
      https://x.com/peter_brit/status/1775041789889491437?s=46&t=1nHn7IXseo2gJ7ymtRCgUA

      This ship is sinking fast!
      👍️ 3 👏 3
      TiltMyBrain TiltMyBrain 10 months ago
      insider selling in 3...2...1...
      👍️ 3 💯 3 😂 1 🤣 1

      Your Recent History

      NASDAQ
      NVCR
      NovoCure
      LSE
      ROO
      Deliveroo
      BOV
      P2NB34Q
      Penumbra
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads